Info

Provectus Pharmaceuticals, Inc. (Provectus) develops, licenses and markets and plans to sell products in three sectors of the healthcare industry, which include Over-the-counter products (OTC products), Prescription drugs, and Medical device systems. The Company conducts its business through its seven wholly owned subsidiaries, namely Xantech Pharmaceuticals, Inc., Pure-ific Corporation, Provectus Biotech, Inc., Provectus Devicetech, Inc., Provectus Imaging, Inc., IP Tech, Inc., and Provectus Pharmatech, Inc. The Company’s prescription drug products encompass the areas of dermatology and oncology and involve several types of small molecule-based drugs. Its medical device systems include therapeutic and cosmetic lasers, while its OTC products address markets primarily involving skincare applications.(Source: 10KSB)